$15.47
-0.47[-2.95%]
At close: Apr 26
$15.47
0[0.00%]
After Hours: 4:00PM EDT
Kyverna Therapeutics
(NASDAQ:KYTX)Kyverna Therapeutics Stock (NASDAQ:KYTX), Quotes and News Summary
Kyverna Therapeutics Stock (NASDAQ: KYTX) stock price, news, charts, stock research, profile.
| Open | $15.750 |
| Close | $15.470 |
| Volume / Avg. | 705.577K / 489.859K |
| Day Range | 15.430 - 16.160 |
| 52 Wk Range | 15.680 - 35.060 |
| Market Cap | $666.993M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 24 |
| Short Interest | 6.07% |
| Days to Cover | 3.37 |
Recent News
No news found
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Kyverna Therapeutics Inc.
Sector
Health Care
Industry
Biotechnology
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing ...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Kyverna Therapeutics (KYTX) stock?
You can purchase shares of Kyverna Therapeutics (NASDAQ: KYTX) through any online brokerage.
Who are Kyverna Therapeutics's (KYTX) competitors?
Other companies in Kyverna Therapeutics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Cabaletta Bio (NASDAQ:CABA), 89bio (NASDAQ:ETNB), Zentalis Pharma (NASDAQ:ZNTL) and Cogent Biosciences (NASDAQ:COGT).
What is the target price for Kyverna Therapeutics (KYTX) stock?
The latest price target for Kyverna Therapeutics (NASDAQ: KYTX) was reported by JP Morgan on Monday, March 4, 2024. The analyst firm set a price target for 39.00 expecting KYTX to rise to within 12 months (a possible 152.10% upside). 2 analyst firms have reported ratings in the last year.
Current Stock Price for Kyverna Therapeutics (KYTX)?
The stock price for Kyverna Therapeutics (NASDAQ: KYTX) is $15.47 last updated April 26, 2024 at 4:00 PM EDT.
Does Kyverna Therapeutics (KYTX) pay a dividend?
There are no upcoming dividends for Kyverna Therapeutics.
When is Kyverna Therapeutics (NASDAQ:KYTX) reporting earnings?
Kyverna Therapeutics’s Q1 earnings are confirmed for Sunday, May 12, 2024.
Is Kyverna Therapeutics (KYTX) going to split?
There is no upcoming split for Kyverna Therapeutics.
What sector and industry does Kyverna Therapeutics (KYTX) operate in?
Kyverna Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.